Decursin T3S1416
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
1. Decursin is able to attenuate kainic acid-induced seizures and could have potential as an antiepileptic drug. 2. Decursin exhibits hepatoprotective effects , potentially by inhibiting the TGF-_1 induced NOX activation and Smad signaling. 3. Decursin ha
CAS nr:
5928-25-6
Purity:
98%
Molecular Weight:
328,36
SMILES:
C\C(C)=C\C(=O)O[C@H]1Cc2cc3ccc(=O)oc3cc2OC1(C)C
Formula:
C19H20O5
Pathway:
Apoptosis,Cytoskeletal Signaling,Chromatin/Epigenetic
Target:
Apoptosis,PKC,PKC
